MR Imaging Screening of the Contralateral Breast in Patients with Newly Diagnosed Breast Cancer: Preliminary Results

PURPOSE: To investigate the role of screening magnetic resonance (MR) imaging in the detection of synchronous contralateral breast cancer in patients with newly diagnosed breast cancer.

MATERIALS AND METHODS: Between January 1999 and July 2001, 182 patients with newly diagnosed breast cancer (after either core or excisional biopsy with positive or close margins of resection) underwent bilateral contrast material–enhanced MR imaging at 1.5 T with a dedicated bilateral breast multicoil array. The contralateral breast was imaged for cancer screening. Family history of breast cancer, index cancer histology, breast density, and age at diagnosis of first breast cancer were assessed as potential risk factors for synchronous contralateral breast cancer.

RESULTS: Fifteen patients (8.2%) had a suspicious enhancing lesion depicted in the contralateral breast. Seven patients (3.8%) had malignant results: ductal carcinoma in situ (DCIS) in four, invasive ductal carcinoma with DCIS in two, and invasive ductal carcinoma in one. Eight patients (4.4%) had benign results: fibrocystic changes in four, atypical ductal hyperplasia in two, atypical lobular hyperplasia and focal lobular carcinoma in situ in one, and ductal hyperplasia in one. Six patients with negative MR findings underwent prophylactic mastectomy; no malignancy was found. No significant differences were noted among patients with true-positive (n = 7), false-positive (n = 8), or negative (n = 167) MR findings with regard to family history of breast cancer (P < .27), index cancer histology (P < .19), breast density (P < .34), or age at diagnosis of first breast cancer (P < .10).

CONCLUSION: The preliminary results demonstrate the feasibility of using MR imaging of the breast in a screening role, specifically to evaluate the contralateral breast in patients with newly diagnosed breast cancer to detect mammographically and clinically occult synchronous breast cancer.

© RSNA, 2003

References

  • 1 Donovan AJ. Bilateral breast cancer. Surg Clin North Am 1990; 70:1141-1149. Crossref, MedlineGoogle Scholar
  • 2 Hungness ES, Safa M, Shaughnessy EA, et al. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the two breasts. Surgery 2000; 128:702-707. Crossref, MedlineGoogle Scholar
  • 3 Heron DE, Komarnicky LT, Hyslop T, et al. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000; 88:2739-2750. Crossref, MedlineGoogle Scholar
  • 4 Leis HP. Managing the remaining breast. Cancer 1980; 46:1026-1030. Crossref, MedlineGoogle Scholar
  • 5 Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501. LinkGoogle Scholar
  • 6 Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191:625-631. LinkGoogle Scholar
  • 7 Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170:681-686. LinkGoogle Scholar
  • 8 Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171:95-103. LinkGoogle Scholar
  • 9 American College of Radiology. Breast imaging reporting and data system (BI-RADS) 3rd ed. Reston, Va: American College of Radiology, 1998. Google Scholar
  • 10 Insko EK, Schnall MD, Connick TJ, Orel SG. Multi-coil array for high resolution imaging of the breast. Magn Reson Med 1997; 37:778-786. Crossref, MedlineGoogle Scholar
  • 11 Orel SG, Schnall MD, Newman RW, et al. MR imaging-guided localization and biopsy of breast lesions: initial experience. Radiology 1994; 193:97-102. LinkGoogle Scholar
  • 12 Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC. MR imaging of ductal carcinoma in situ. Radiology 1997; 202:413-420. LinkGoogle Scholar
  • 13 Soderstrom CE, Harms SE, Copit DS, et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996; 201:427-432. LinkGoogle Scholar
  • 14 Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196:115-122. LinkGoogle Scholar
  • 15 Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213:881-888. LinkGoogle Scholar
  • 16 Slanetz PJ, Edmister WB, Weisskoff RM, et al. Occult contralateral breast cancer detected by breast MR (abstr). Radiology 1998; 209(P):467. Google Scholar
  • 17 Rieber A, Merkle E, Bohm W, Brambs HJ, Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997; 21:773-779. Crossref, MedlineGoogle Scholar
  • 18 Fisher ER, Fisher B, Sass R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No 4). XI. Bilateral breast cancer. Cancer 1984; 54:3002-3011. Crossref, MedlineGoogle Scholar

Article History

Published in print: Mar 2003